Results 151 to 160 of about 23,377 (288)

S3 guideline diagnostics and therapy in alopecia areata – Part 2: Therapy, psychosocial and cosmetic support

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary This second part of the S3 guideline on the diagnosis and treatment of alopecia areata (AA), presents key recommendations on topical and systemic therapy, quality of life and support services. The first part of the guideline, published separately, covers the definition and content of epidemiology and diagnosis as well as comorbidities, risk and
Ulrike Blume‐Peytavi, Andria Constantinou, Tsenka Tomova‐Simitchieva, Adrian Tanew, Michael Sticherling, Hermann Girschick, Annika Vogt, Uwe Schwichtenberg, Uwe Gieler, André Märtens, Kerstin Zienert, Claudia Stenders, Ricardo Niklas Werner, Doris Wilborn   +13 more
wiley   +1 more source

Entecavir-Induced Lichenoid Drug Eruption: A Case Report. [PDF]

Cureus
Sushantika S, Yadav P, Sethi J, Nanda S, Saini K.   +4 more
europepmc   +1 more source

Copaiba Balsam‐Induced Contact Dermatitis Mimicking Wells' Cellulitis in a Child

Contact Dermatitis, EarlyView.
Nathalia Bellon, Angéline Girault, Morgane Seyler, Annonciade Frassati‐Biaggi, Anne Welfringer, Christine Bodemer   +5 more
wiley   +1 more source

Daratumumab induced lichenoid drug eruption. [PDF]

JAAD Case Rep
Perz C, Wissman T, Montebello A.
europepmc   +1 more source

Drug induced bullous fixed drug eruption: a case report

Bullous fixed drug eruption, which is a cutaneous adverse drug reaction, is commonly seen with antimicrobials and analgesics. Bullous drug eruptions are infrequent, but because they pose a challenge both to affected patients and to treating physicians ...
Emperumal, Tamil Selvi
core   +1 more source

S1 Guideline: Therapy of generalized pustular psoriasis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary The S1 guideline “Therapy of generalized pustular psoriasis (GPP)” is a German guideline developed in accordance with the criteria of the AWMF. The full version addresses clinical presentation, pathogenesis, diagnosis and differential diagnosis, comorbidities, and therapy.
Rotraut Mößner, Neda Cramer, Sascha Gerdes, Ulrike Hüffmeier, Andreas Körber, Kai Krause, Christian Kromer, Katharina Antonia Langen, Sandra Philipp, Knut Schäkel, Michael P. Schön, Michael Schultheis, Lukas Sollfrank, Petra Staubach, Michael Sticherling, Johannes Wohlrab, Dagmar Wilsmann‐Theis, Cornelia Paul   +17 more
wiley   +1 more source

Maculopapular-Type Drug Eruption Caused by Cetuximab. [PDF]

Cureus
Ikegawa N, Saito-Sasaki N, Sawada Y.
europepmc   +1 more source

Drug Eruptions

International Journal of Clinical Practice, 1968
openaire   +2 more sources

Clinical Efficacy of CBCT and 3D‐Printed Replicas in Molar Autotransplantation: A Controlled Clinical Trial

Dental Traumatology, Volume 41, Issue 2, Page 161-170, April 2025.
ABSTRACT Background/Aim To evaluate the efficacy of the combined cone‐beam (CBCT)/3D‐replicas protocol on the clinical and radiographic outcomes of autotransplanted molars. Material and Methods Controlled clinical trial registered ISRCTN13563091 from August 2019 to September 2022.
Miks Lejnieks, Ilze Akota, Gundega Jākobsone, Laura Neimane, Sergio E. Uribe   +4 more
wiley   +1 more source

Nicotine-induced bullous fixed drug eruption

JAAD Case Reports, 2022
Brynn Sargent, BS, Lina Saeed, MD, Dani Zhao, MD, Anna-Marie Hosking, MD, Hadas Skupsky, MD, Maryam Safaee, MD   +5 more
doaj   +1 more source